Biohacking experiments in the field of biology includes the use of drugs or gene editing or implants which improve the capabilities or qualities of living organisms. This is done by the individuals or groups working in a scientific research environment or in a traditional medical laboratory. Biohacking is managing one's own biology with the combination of nutritional, electronic, and medical technologies. It is also referred to as Do-It-Yourself (DIY) biology. The concept of biohacking has brought an absolute change in the field of synthetic biology. Biohacking has developed an urge for the development and innovation of new products that improve our health, fight ageing, and up our life expectancy. It combines the aspects of technology and synthetic biology. Laboratory experiments are conducted by scientists and research individuals to explore new avenues in biotechnology, genetic engineering, and molecular biology.
Biohackers embark on numerous experimentations on the body such as monitoring of the heart rate or insertion of microchips to control the stress level. Biohackers have developed and are developing various products to explore the different functions taking place in a human body. Some of the remarkable products from biohacking market include smart drugs, microchips, magnetic fingertips, brain sensors, RFID implants, bacterial and yeast strains, body sensors, and smart blood pressure monitor health trackers.
Market Dynamics
The increasing prevalence of chronic diseases, such as diabetes and cancer, is one major driving force that is triggering the market growth. As per the reports of the American Cancer Association, 2020, 13% of the U.S. population are diagnosed with cancer before they cross the age of 20. The National Diabetes Statistics Report, 2020 indicates that 10.5% of the U.S. population suffers from diabetes. Early diagnosis of the chronic disease is the only way out and is a belief that increasing prevalence of the same is triggering the biohacking market growth.
Key features of the study:
- This report provides in-depth analysis of the global biohacking market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global biohacking market based on the following parameters – Company Highlights, Types Portfolio, Key Highlights, Financial Performance, and Market Strategies.
- Key companies covered as a part of this study include Thync Global Inc., Apple Inc., HVMN, Synbiota, MoodMetric, THE ODIN, Fitbit, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global biohacking market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biohacking market
Detailed Segmentation:
- Global biohacking market, By Type:
- Global biohacking market, By Product:
- Smart Drugs
- Sensors
- Strains
- Others
- Global biohacking market, By Application:
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- Global biohacking market, By End User:
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- Global biohacking Market, By Region:
- North America
- By Type
- By Product
- Smart Drugs
- Sensors
- Strains
- Others
- By Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- By End User
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- By Country
- Latin America
- By Type
- By Product
- Smart Drugs
- Sensors
- Strains
- Others
- By Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- By End User
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Type
- By Product
- Smart Drugs
- Sensors
- Strains
- Others
- By Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- By End User
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Type
- By Product
- Smart Drugs
- Sensors
- Strains
- Others
- By Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- By End User
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Type
- By Product
- Smart Drugs
- Sensors
- Strains
- Others
- By Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- By End User
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Type
- By Product
- Smart Drugs
- Sensors
- Strains
- Others
- By Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
- By End User
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
- By Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
-
- Thync Global Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Apple Inc.
- HVMN
- Synbiota
- MoodMetric
- THE ODIN
- Fitbit, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
